Clinical Trial

Immunogenicity of HPV Vaccine in Transplant Recipients.

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-09-22; most recent amendment 2026-04-29.
Status change: Recruiting → Active, Not Recruiting 2025-07-18
Status change: Not Yet Recruiting → Recruiting 2023-08-09
Trial Details
NCT Number NCT05557370
Lead Sponsor Medical College of Wisconsin
Collaborators: Merck Sharp & Dohme LLC
Conditions Chronic Kidney Diseases, Kidney Transplant
Enrollment 30 participants
Start Date 2023-06-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-01